Project Details
Description
Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/18 → 12/31/23 |
Funding
- PHARMACYCLICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.